What's Happening?
The U.S. Department of the Treasury has issued a Notice of Proposed Rulemaking (NPRM) to substantially broaden prohibitions on U.S. outbound investments, particularly in Chinese technology sectors. This proposal aims to implement the Comprehensive Outbound
Investment National Security Act of 2025 (COINS Act). The NPRM introduces new barriers for cross-border collaboration with Chinese biotech companies and bans U.S. investment in certain Chinese artificial intelligence (AI) firms. Key changes include new prohibitions on a wide range of investments in the Chinese biotech sector, a ban on investments in most Chinese AI companies (including those relying on third-party models), and an expansion of the definition of 'covered foreign person' to include entities subject to the direction or control of such persons. The definition of 'develop' is also broadened to include activities conducted through affiliates, transforming plans into products, and high-level oversight. Comments on the NPRM are due by December 7, 2026.
Why It's Important?
This proposed rule signifies a major escalation in the U.S. government's efforts to restrict the flow of American capital and expertise to strategic technology sectors in China. By expanding the scope of prohibited investments in biotechnology and AI, the Treasury aims to safeguard U.S. national security interests and prevent potential adversaries from leveraging American innovation for military or strategic advantage. The broadened definitions of 'develop' and 'covered foreign person' will significantly increase compliance burdens for U.S. investors, requiring more extensive due diligence and potentially deterring investments in a wider array of Chinese entities. This move could lead to a decoupling of technological ecosystems, impacting global supply chains, research collaborations, and the competitive landscape of critical industries. U.S. companies and investors operating in or considering investments in these sectors will face heightened scrutiny and regulatory complexity, potentially leading to reduced investment opportunities and increased operational costs.
What's Next?
Interested parties have until December 7, 2026, to submit comments on the NPRM, providing a crucial opportunity to influence the final rule. Following this period, the Treasury will review the feedback and finalize the regulations. The existing regulations at 31 C.F.R. Part 850 will remain in effect until the new rule is finalized. U.S. persons and entities involved in cross-border investments, particularly in the biotech and AI sectors, should immediately assess the potential implications of these proposed changes on their current and planned transactions. The Treasury has also established a non-binding feedback process for specific transactions, though investors remain responsible for identifying prohibited and notifiable activities through due diligence. The final rule is expected to reshape the landscape of U.S. outbound investment in critical technologies.
Beyond the Headlines
The proposed expansion of outbound investment prohibitions reflects a deeper strategic competition between the U.S. and China, extending beyond traditional trade disputes to encompass technological leadership and national security. This policy aims to create a 'small yard, high fence' approach, selectively restricting investments in areas deemed critical while allowing broader economic engagement. However, such measures raise questions about their effectiveness in a globally interconnected economy and the potential for unintended consequences, such as accelerating China's indigenous technological development or prompting retaliatory measures. The ethical implications of restricting scientific and technological collaboration, particularly in fields like biotechnology, also warrant consideration. This move underscores a long-term shift towards a more controlled and national security-driven approach to international investment, potentially altering the global flow of capital and innovation for decades to come.
